Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 3/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | EP300 | Q09472 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CPB1 | P15086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3278815 | 0.89 | GRIK1 (0.40) | GRIK1GRIK2ALDH1A1CHRM2CHRM4 | |
| SCHEMBL9644125 | 0.83 | ALDH1A1 (0.36) | GRIK1GRIK2ALDH1A1 | |
| SCHEMBL3278162 | 0.83 | GRIK1 (0.42) | GRIK1GRIK2CHRM2EP300LMNA | |
| SCHEMBL5488690 | 0.82 | GRIK1 (0.33) | GRIK1GRIK2ALDH1A1 | |
| SCHEMBL1921773 | 0.82 | GRIK1 (0.38) | GRIK1GRIK2EP300CPB1 | |
| SCHEMBL3277773 | 0.80 | EP300 (0.44) | GRIK1CHRM1EP300LMNAPOLB | |
| SCHEMBL3282826 | 0.80 | EP300 (0.44) | GRIK1CHRM1EP300LMNAPOLB | |
| SCHEMBL3284713 | 0.80 | EP300 (0.44) | GRIK1CHRM1EP300LMNAPOLB | |
| SCHEMBL37961 | 0.78 | ALDH1A1 (0.36) | ALDH1A1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL37962 | 0.78 | ALDH1A1 (0.36) | ALDH1A1CHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2300067-B1 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIV OF BELFAST (GB) | 2017-10-25 | — | — | EP | claimed |
| US-20160136286-A1 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2016-05-19 | — | — | US | claimed |
| US-9271928-B2 | Drug delivery composition | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2016-03-01 | — | — | US | claimed |
| US-20110165114-A1 | DRUG DELIVERY COMPOSITION | QUEEN'S UNIVERSITY OF BELFAST, THE (GB) | 2011-07-07 | — | — | US | claimed |
| EP-2300067-A2 | DRUG DELIVERY COMPOSITION | The Queen's University of Belfast (GB) | 2011-03-30 | — | — | EP | claimed |
| WO-2009147372-A2 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-12-10 | — | — | WO | claimed |
| US-20070113353-A1 | Polymeric Surface Treatment Compositions | THE CLOROX COMPANY | 2007-05-24 | — | — | US | claimed |
| EP-2300067-B1 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIV OF BELFAST (GB) | 2017-10-25 | — | — | EP | disclosed |
| US-20160136286-A1 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2016-05-19 | — | — | US | disclosed |
| US-9271928-B2 | Drug delivery composition | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2016-03-01 | — | — | US | disclosed |
| US-8450359-B2 | Polymer-supported photosensitizers for the generation of singlet oxygen | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2013-05-28 | — | — | US | disclosed |
| US-20110165114-A1 | DRUG DELIVERY COMPOSITION | QUEEN'S UNIVERSITY OF BELFAST, THE (GB) | 2011-07-07 | — | — | US | disclosed |
| EP-2300067-A2 | DRUG DELIVERY COMPOSITION | The Queen's University of Belfast (GB) | 2011-03-30 | — | — | EP | disclosed |
| US-20100160487-A1 | Polymeric Surface Treatment Compositions | THE CLOROX COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
| US-7699941-B2 | Polymeric surface treatment compositions | THE CLOROX COMPANY (US) | 2010-04-20 | — | — | US | disclosed |
| WO-2009147372-A2 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-12-10 | — | — | WO | disclosed |
| US-20090292357-A1 | MATERIAL AND USES THEREOF | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-11-26 | — | — | US | disclosed |
| EP-1984439-A1 | MATERIAL AND USES THEREOF | The Queen's University of Belfast (GB) | 2008-10-29 | — | — | EP | disclosed |
| WO-2007088392-A1 | MATERIAL AND USES THEREOF | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2007-08-09 | — | — | WO | disclosed |
| US-20070113353-A1 | Polymeric Surface Treatment Compositions | THE CLOROX COMPANY | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110165114-A1 | DRUG DELIVERY COMPOSITION | ECPAS, ABCB11, ABCB1 | GRIK1 2170/4885GRIK2 2976/4885ALDH1A1 1965/4885 |
| US-20160136286-A1 | DRUG DELIVERY COMPOSITION | ECPAS, ABCB11, ABCB1 | GRIK1 2170/4885GRIK2 2976/4885ALDH1A1 1965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.